Sun Pharmaceutical Industries

SUNPHARMA · NSE · INR

₹1,801.00Change from previous close: −0.86%Absolute change: −₹15.60

Close · October 1, 2026

Company profile

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Sun House, 400063, Mumbai
Employees
47,000
Listing
SUNPHARMA · NSE
Currency
INR
ISIN
INE044A01036